Topics and Expertise: World Health Organization (WHO)

Rosa Rodriguez-Monguio appointed to newly formed WHO group

Rodriguez-Monguio has been appointed to a newly formed advisory group at the World Health Organization focused on antimicrobial resistance.

Data-driven drug dosing speeds tuberculosis treatment to four months

A large trial of a new drug regimen for tuberculosis, designed in part by School researchers, leads to a new WHO recommendation for treating the disease.

Aweeka study details impact of HIV drugs on malaria treatment in children

Sub-Saharan Africa is home to a billion people and to overlapping health burdens, including the world’s highest rates of both malaria and HIV infection.

Bero heads new WHO center studying, promoting global access to vital drugs

The office of Lisa Bero, PhD, on UCSF’s Laurel Heights campus has long been a key portal between the School of Pharmacy and the world at large, including countries where billions of people cannot get even the most vital life-saving drugs.

Bero represents The Cochrane Collaboration on the World Health Assembly

Lisa Bero, PhD, a faculty member in the UCSF School of Pharmacy was named to represent The Cochrane Collaboration on the World Health Assembly of the World Health Organization (WHO) after the Collaboration was awarded an Assembly

WHO plan for global tobacco control contested by US

A plan seeded in 1996 by the World Health Organization for an international agreement, [Framework Convention on Tobacco Control] [link defunct]," is undergoing final discussions by member states before submission to the World Health Assembly in May.